Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PKP4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
C1orf162 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MMAB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM210B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PIAS2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC90784 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UQCC2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FOCAD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SSU72 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SNX25 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NGLY1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EZH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EHD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors
NPAS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DPF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DCTN5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDIA2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on